FDA v. R.J. Reynolds Vapor Co.
Case Overview
The Supreme Court considers whether the FDA's multi-step authorization process for e-cigarette products — in which the agency imposed arbitrary and inconsistent standards after applicants expended years of resources complying — was arbitrary and capricious under the Administrative Procedure Act. The case is a significant test of the APA's arbitrary and capricious standard post-Loper Bright.
Decision
Opinion of the Court
The Facts
R.J. Reynolds Vapor submitted a premarket tobacco product application for flavored vapor products. The FDA denied the application, applying the same public health framework at issue in Wages and White Lion: whether the products' benefits to adult smokers outweighed the risk of youth initiation. The company argued the FDA applied a moving standard and failed to give adequate consideration to its evidence. The case was closely related to, and often litigated in parallel with, the Wages and White Lion proceedings.
The Application
Under the State Farm arbitrary and capricious standard, the FDA must articulate a rational basis for its balancing of competing public health interests and respond meaningfully to significant evidence presented by the applicant. R.J. Reynolds argued that the FDA's denial failed this test by either ignoring or inadequately addressing the company's evidence regarding adult smoking cessation benefits—evidence the FDA had specifically requested as part of its information-gathering process. The court examined whether the FDA's public health framework—weighing youth initiation risk against adult smoking cessation benefits—was applied consistently across applications or whether the agency had shifted its criteria in ways that rendered R.J. Reynolds' denial arbitrary. Ultimately, the case turns on whether an agency applying a discretionary balancing test can deny an application while omitting reasoned discussion of factual evidence directly supporting one side of that balance.
The Conclusion
**FDA v.** R.J. Reynolds Vapor is a companion to Wages and White Lion and presents the same core legal question about FDA's premarket tobacco review standard. The ruling determines whether the FDA can consistently apply population-level public health criteria that weigh youth initiation risk against adult cessation benefits, or whether denial of applications supported by adult-cessation evidence is arbitrary. The combined effect of these cases sets the legal framework for FDA's authority over the e-cigarette market.
No circuit court data for this case.
Flag an issue
This tracker is maintained by BrynoDC and is free because readers fund it. Support